Evidence map›Paper›PMID 26606133›Full record

ArticlePloS one2015

Roemerine Improves the Survival Rate of Septicemic BALB/c Mice by Increasing the Cell Membrane Permeability of Staphylococcus aureus.

Sunjun Yin, Gaoxiong Rao, Jin Wang, Liyang Luo, Gonghao He, Chengying Wang, Chaoyu Ma, Xiaoxing Luo, Zheng Hou, Guili Xu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Repurposing fusidic acid as an antimicrobial against enterococci with a low probability of resistance development.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. A critical review: traditional uses, phytochemistry, pharmacology and toxicology ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2020
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sunjun YinDepartment of Pharmacy, Kunming General Hospital of Chengdu Military Region, Kunming, Yunnan, 650500, China.
Gaoxiong RaoYunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650500, China.
Jin WangDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Liyang LuoDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Gonghao HeDepartment of Pharmacy, Kunming General Hospital of Chengdu Military Region, Kunming, Yunnan, 650500, China.
Chengying WangYunnan University of Traditional Chinese Medicine, Kunming, Yunnan, 650500, China.
Chaoyu MaKunming Medical University, Kunming, Yunnan, 650500, China.
Xiaoxing LuoDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Zheng HouDepartment of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
Guili XuDepartment of Pharmacy, Kunming General Hospital of Chengdu Military Region, Kunming, Yunnan, 650500, China.
Air Force Medical University · CNKunming General Hospital of Chengdu Military Command · CNYunnan University of Traditional Chinese Medicine · CNKunming Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Staphylococcus aureus is one of the most frequently occurring hospital- and community-associated pathogenic bacteria featuring high morbidity and mortality. The occurrence of methicillin-resistant S. aureus (MRSA) has increased persistently over the years. Therefore, developing novel anti-MRSA drugs to circumvent drug resistance of S. aureus is highly important. Roemerine, an aporphine alkaloid, has previously been reported to exhibit antibacterial activity. The present study aimed to investigate whether roemerine can maintain these activities against S.aureus in vivo and further explore the underlying mechanism. We found that roemerine is effective in vitro against four S. aureus strains as well as in vivo against MRSA insepticemic BALB/c mice. Furthermore, roemerine was found to increase cell membrane permeability in a concentration-dependent manner. These findings suggest that roemerine may be developed as a promising compound for treating S. aureus, especially methicillin-resistant strains of these bacteria.

Indexed as

AlkaloidsAnimalsAnti-Bacterial AgentsCell Membrane PermeabilityDisease Models, AnimalDrugs, Chinese HerbalMiceMice, Inbred BALB CSepsisStaphylococcal InfectionsStaphylococcus aureusAlkaloidsAnti-Bacterial AgentsDrugs, Chinese Herbalroemerine

Identifiers

PMID26606133
PMCPMC4659618
OpenAlexW2176958659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.